Main Menu

Yearly Archives: 2017


Altmetric: 5More detail Article | OPEN Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

August 18th, 2017|News|

Trails and Tribulations

Not all who wander are lost…I have seen this a lot lately, adorning the shirts and walls amongst varied communities—from artists to drifters to star-seeking entrepreneurs to anyone who just likes the idea of following an unbeaten path. While there is nothing wrong with a good quote that inspires you to one day seek adventure [...]

August 11th, 2017|Big Dam Bridge 100, News|

Subaru and Leukemia & Lymphoma Society Blanket Myeloma Institute with Love

Gareth Morgan, M.D., Ph.D., (third from left) poses with patients and staff at the Myeloma Institute who welcomed the donation of blankets. Aug. 4, 2017 | Patients of the UAMS Myeloma Institute will soon be wrapped in additional care and comfort, thanks to the Subaru Loves to Care initiative launched last year by the vehicle [...]

August 4th, 2017|News|

From the Director

Dear Readers, Quality of life for patients is a top priority at the Myeloma Institute.  Our team is committed to providing a comprehensive, holistic experience, including effective disease management and emotional support for patients, family members and caregivers. We believe that patients should be able to live their lives as fully as possible with minimal [...]

July 27th, 2017|Spring 2017|

Bone Disease in Myeloma

Donghoon Yoon, Ph.D., in his lab where his focus is on the factors and mechanisms of bone metabolism in myeloma Bone disease is a hallmark of myeloma, affecting up to 90 percent of patients. An unexplained fracture or bone pain can be the first sign that something is not right and often leads patients to [...]

July 27th, 2017|Spring 2017|

Bone Remodeling Clinical Trial Assessment

Carolina Schinke, M.D., assistant professor, conducts research that leads to development of new clinical trials. Bone disease is a major issue for the majority of multiple myeloma patients.  Lytic lesions, fractures and collapse of vertebra in the spine — primary causes of pain and debilitation — can significantly compromise quality of life. Clinical treatment for [...]

July 27th, 2017|Spring 2017|

Partners in Care

Bobbie Rainey receiving a post-surgery exam by orthopaedic surgeon Corey Montgomery, M.D. Bobbie Rainey from Gould, Arkansas, came to the Myeloma Institute in September of 2010.  She was experiencing pain all over her body, especially her lower back, legs and arms, in addition to other symptoms of myeloma. Due to a persistent bone lesion in [...]

July 27th, 2017|Myeloma Magazine, Spring 2017|

Plasma Cell Neoplasm — A Brief Primer

While multiple myeloma is the primary disease treated at the Myeloma Institute, other plasma cell neoplasms are also the focus of our research and treatment regimens. What is a Plasma Cell Neoplasm? A neoplasm is an abnormal mass of tissue that results when cells divide more than they should or do not die when they [...]

July 27th, 2017|Myeloma Magazine, Spring 2017|


Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker A new publication in Blood Cancer Journal 24 February 2017, PMID: 28234347 Primary Authors: Shweta Chavan, Ph.D., and Brian Walker, Ph.D. Targeted gene sequencing was conducted on 578 cases of plasma cell neoplasms, including monoclonal gammopathy of undermined [...]

July 27th, 2017|Myeloma Magazine, Spring 2017|

Giving Back and Creating a Legacy

The Myeloma Institute is a trailblazer in the development of innovative treatments for myeloma and other plasma cell neoplasms. With a firm commitment to helping patients regain their lives and look forward to a disease-free future, the institute’s health care team provides expertise while extending compassion and encouragement. Patients and families frequently ask how they [...]

July 27th, 2017|Myeloma Magazine, Spring 2017|